Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
05/10/2001 | CA2388955A1 Recombinant fusion molecules |
05/10/2001 | CA2388822A1 27 human secreted proteins |
05/10/2001 | CA2388657A1 New combination comprising a beta 2 (.beta.)2 adreno receptor agonist and a leukotriene receptor antagonist |
05/10/2001 | CA2388333A1 Method and compositions for treating pulmonary diseases |
05/10/2001 | CA2388202A1 Polymorphic form of a tachykinin receptor antagonist |
05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
05/10/2001 | CA2387785A1 Human transferase molecules |
05/10/2001 | CA2387754A1 10 human secreted proteins |
05/10/2001 | CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
05/10/2001 | CA2386938A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
05/10/2001 | CA2386641A1 32 human secreted proteins |
05/09/2001 | EP1097926A1 Thiobenzimidazole derivatives |
05/09/2001 | EP1097711A2 Treatment of pulmonary hypertension |
05/09/2001 | EP1097142A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
05/09/2001 | EP1097139A1 Quinoline derivatives |
05/09/2001 | EP1096932A2 Antihypertensive combination of valsartan and calcium channel blocker |
05/09/2001 | EP1096928A1 New pharmaceutical preparation and method |
05/09/2001 | EP0633776B1 Compounds useful for treating allergic and inflammatory diseases |
05/09/2001 | CN1294632A Compsns. derived from i(mycobacterium vaccae) and methods for their use |
05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
05/09/2001 | CN1294588A Spiropiperidine derivatives |
05/09/2001 | CN1294581A Pyridine derivative and pharmaceutical contg. same |
05/09/2001 | CN1293991A Medicine for treating asthma |
05/09/2001 | CN1293970A Chinese medicine for curing cold by omphalotherapy and its preparing process |
05/09/2001 | CN1293960A Antivirus compound medicine |
05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
05/08/2001 | US6229013 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
05/08/2001 | US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
05/08/2001 | US6228619 Glucosaminidase |
05/08/2001 | US6228584 Nucleotide sequences for use in the detection of streptococcus |
05/08/2001 | US6228398 Dosage form for increasing patient compliance by reducing dosage frequency; attention deficit disorder, methylphenidate or salts |
05/08/2001 | US6228394 Supercritical fluid extraction of mould lubricant from hard shell capsules |
05/08/2001 | US6228347 Antioxidant gel for gingival conditions |
05/03/2001 | WO2001031029A2 Human sphingosine kinase gene |
05/03/2001 | WO2001031016A2 Processed human chemokines phc-1 and phc-2 |
05/03/2001 | WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel |
05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
05/03/2001 | WO2001030779A1 Naphthyridine derivatives |
05/03/2001 | WO2001030777A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors |
05/03/2001 | WO2001030774A1 Substituted indoles for modulating nfkb activity |
05/03/2001 | WO2001030772A1 Compounds and their use as cysteine protease inhibitors |
05/03/2001 | WO2001030767A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
05/03/2001 | WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors |
05/03/2001 | WO2001030759A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
05/03/2001 | WO2001030390A2 Method |
05/03/2001 | WO2001030350A1 Treating sleep disorders using desloratadine |
05/03/2001 | WO2001030347A1 Treatment or prevention of hypotension and shock |
05/03/2001 | WO2001030326A1 Treatment of emphysema using rar selective retinoid agonists |
05/03/2001 | WO2001013893A3 Use of simple amino acids to form porous particles |
05/03/2001 | WO2000066107A3 Antimalarian agents for the treatment of asthma |
05/03/2001 | DE19952147A1 Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New cyclopropanes, pharmaceutical compositions containing them and methods for their preparation |
05/03/2001 | DE19951671A1 2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionssäure-Natriumsalz und seine Verwendung als Endothelinantagonist and its use as an endothelin antagonist |
05/03/2001 | DE19951360A1 Substituierte Indole Substituted indoles |
05/03/2001 | CA2389127A1 Human sphingosine kinase gene |
05/03/2001 | CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel |
05/03/2001 | CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
05/03/2001 | CA2389012A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
05/03/2001 | CA2388995A1 Method |
05/03/2001 | CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors |
05/03/2001 | CA2388119A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors |
05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
05/03/2001 | CA2386908A1 Treating sleep disorders using desloratadine |
05/03/2001 | CA2385178A1 Naphthyridine derivative |
05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
05/02/2001 | EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
05/02/2001 | EP1095662A1 New vaccine composition and use of surfactants as immuno-adjuvant |
05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
05/02/2001 | EP1095060A1 Galectin 11 |
05/02/2001 | EP1095057A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
05/02/2001 | EP1095040A1 New benzoxazoles with pde-inhibiting activity |
05/02/2001 | EP1095039A2 New pharmaceutically active compounds |
05/02/2001 | EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules |
05/02/2001 | EP1095021A1 Quinoline derivatives |
05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
05/02/2001 | EP1095003A1 Cytokine production and tyrosine kinase inhibitors |
05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
05/02/2001 | EP1094800A2 PEPTIDYL-PROLYL $i(CIS)-TRANS ISOMERASE INHIBITORS AND USES THEREFOR |
05/02/2001 | CN1293661A Pyridazinone hydrochloride compound and method for producing the same |
05/02/2001 | CN1293194A New 7-amino pyrido[2,3-d] pyrimidine derivative |
05/02/2001 | CN1293051A Liquid medicine for treating rhinitis |
05/02/2001 | CN1293043A Honeycomb honey and its preparing process |
05/02/2001 | CN1065137C Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor |
05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
05/01/2001 | US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids) |
05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
05/01/2001 | US6224907 Anti-asthma therapy |
05/01/2001 | US6224880 Vaccines |
04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |